Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | MMP1 | P03956 | 2/20 | 0.34 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | MMP9 | P14780 | 2/20 | 0.34 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.34 |
| ▸ | F2 | P00734 | 2/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17185511 | 0.97 | CA2 (0.39) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL17185512 | 0.92 | CA2 (0.32) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1455645 | 0.86 | CA2 (0.38) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL169112 | 0.83 | CA2 (0.50) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL2135574 | 0.81 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL22818194 | 0.81 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL17185508 | 0.81 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1146134 | 0.81 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL3685584 | 0.81 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL1551243 | 0.81 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9505721-B2 | Aromatic imide compound and method for producing same | AZ ELECRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) | 2016-11-29 | — | — | US | disclosed |
| US-20150299132-A1 | AROMATIC IMIDE COMPOUND AND METHOD FOR PRODUCING SAME | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (US) | 2015-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150299132-A1 | AROMATIC IMIDE COMPOUND AND METHOD FOR PRODUCING SAME | H1-0, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HRH4 | CA2 131/4885CA1 1693/4885MMP1 1703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.